Valiant Laboratories Ltd

VALIANTLAB NSE Healthcare Pharmaceuticals
₹127.91
+2.49%
Delayed · cached 15 min
Fair Value Analysis →

Price Chart

Price50-day avg200-day avg

How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.

Strengths

  • Low debt: debt-to-equity of 0.15.
  • Comfortable interest cover: operating profit covers interest about 3 times.
  • Promoters hold a majority stake (74.94%).

!Watch-points

  • Return on equity is on the lower side at -1.2%.
  • Return on capital employed is on the lower side at 0.8%.
  • The company reported a net loss in the latest period.

These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.

Forensic Checks

Altman Z-ScoreGrey zone
2.23

This middle range was less conclusive in Altman’s study — neither clearly safe nor clearly distressed.

Computed without the working-capital term (current-asset split not available for this stock).

Piotroski F-ScoreWeak
3 / 7

The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.

Based on 7 of the 9 signals — the rest need data not available for this stock.

These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.

Key Ratios

Market Cap₹ 695 Cr
Current Price₹ 127.91
High / Low₹ 129.90 / 49.51
Stock P/E45.519577
Book Value₹ 57.20
Dividend Yield0%
ROCE0.75%
ROE-1.20%
Face Value₹ 10.00
Debt to Equity0.15
PEG Ratio
EV / EBITDA61.75
Industry PE35.70
P/B Ratio2.2612524
EPS₹ -0.60
Debt₹ 46 Cr
PAT Margin-1.27%
Cash PAT₹ 3 Cr
ICR3.00
Promoter Holding74.94%
FII Holding0.00%
DII Holding0.00%
Public Holding25.06%

Note on calculated ratios: where a value is not published in the source data, we compute it from the reported financials — Debt to Equity = total borrowings ÷ (equity capital + reserves); EV / EBITDA = (market cap + debt − cash) ÷ (operating profit + depreciation); PEG = P/E ÷ 3-year profit growth %. These may differ slightly from other sources that use different periods or TTM figures. Current Price, Market Cap and P/E reflect the live quote (cached 15 min).

Educational data only. Not a recommendation to buy, sell or hold any security.